FDA greenlights updated mRNA Covid vaccines
The agency’s decision on Monday sets up shots to be rolled out later this month.
Today's Liberal News
By Katherine Ellen Foley
FDA greenlights updated mRNA Covid vaccines
The agency’s decision on Monday sets up shots to be rolled out later this month.
FDA greenlights updated mRNA Covid vaccines
The agency’s decision on Monday sets up shots to be rolled out later this month.
FDA greenlights updated mRNA Covid vaccines
The agency’s decision on Monday sets up shots to be rolled out later this month.
FDA approves first treatment to grant infants protection against RSV
Beyfortus, an antibody from Sanofi and AstraZeneca, is given to babies ahead of their first RSV season.
FDA approves first treatment to grant infants protection against RSV
Beyfortus, an antibody from Sanofi and AstraZeneca, is given to babies ahead of their first RSV season.
FDA approves first treatment to grant infants protection against RSV
Beyfortus, an antibody from Sanofi and AstraZeneca, is given to babies ahead of their first RSV season.
FDA approves first treatment to grant infants protection against RSV
Beyfortus, an antibody from Sanofi and AstraZeneca, is given to babies ahead of their first RSV season.
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
FDA recommends updated target for fall Covid boosters
The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
FDA recommends updated target for fall Covid boosters
The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
FDA recommends updated target for fall Covid boosters
The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
FDA recommends updated target for fall Covid boosters
The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
FDA recommends updated target for fall Covid boosters
The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
FDA recommends updated target for fall Covid boosters
The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
FDA advisers recommend the agency approve the first over-the-counter birth control pill
Independent advisers concluded that HRA Pharma’s application indicated that the benefit of allowing Opill to be sold without a prescription outweighed the risk of consumers taking it improperly.
FDA advisers recommend the agency approve the first over-the-counter birth control pill
Independent advisers concluded that HRA Pharma’s application indicated that the benefit of allowing Opill to be sold without a prescription outweighed the risk of consumers taking it improperly.
FDA advisers recommend the agency approve the first over-the-counter birth control pill
Independent advisers concluded that HRA Pharma’s application indicated that the benefit of allowing Opill to be sold without a prescription outweighed the risk of consumers taking it improperly.
FDA advisers recommend the agency approve the first over-the-counter birth control pill
Independent advisers concluded that HRA Pharma’s application indicated that the benefit of allowing Opill to be sold without a prescription outweighed the risk of consumers taking it improperly.
FDA advisers recommend the agency approve the first over-the-counter birth control pill
Independent advisers concluded that HRA Pharma’s application indicated that the benefit of allowing Opill to be sold without a prescription outweighed the risk of consumers taking it improperly.
FDA approves first over-the-counter Narcan
Narcan can now be sold in gas stations, convenience stores and grocery stores.
FDA approves first over-the-counter Narcan
Narcan can now be sold in gas stations, convenience stores and grocery stores.
FDA approves first over-the-counter Narcan
Narcan can now be sold in gas stations, convenience stores and grocery stores.
FDA approves first over-the-counter Narcan
Narcan can now be sold in gas stations, convenience stores and grocery stores.